Records containing: Kidney Transplant Rejection

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-27
A Seamless Phase 2/3 Randomized, Open-label Study to Investigate Efficacy and Safety of Frexalimab Versus Tacrolimus in Adult Kidney Transplant Recipients
CLINICAL_TRIALS study record update · 2026-04-22
The smartNTx Trial: A Prospective, Randomized Controlled Trial (RCT) to Investigate Additional Interventional Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (KTR)
CLINICAL_TRIALS study record update · 2026-04-20
Belimumab to Mobilise Memory B-cells From Secondary Lymhoid Organs to Improve Memory B-cell HLA-specificity Profiling to Support Delisting for Transplant Access in Highly-sensitized
CLINICAL_TRIALS study record update · 2026-03-27
A Seamless Phase 2/3 Randomized, Open-label Study to Investigate Efficacy and Safety of Frexalimab Versus Tacrolimus in Adult Kidney Transplant Recipients
CLINICAL_TRIALS study record update · 2026-03-18
Trifecta-Kidney cfDNA-MMDx Study: Comparing the DD-cfDNA Test to MMDx Microarray Test, Central HLA Antibody Test, and Histology.
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2026-03-10
Targeting the B Cell Response to Treat Antibody-Mediated Rejection With Carfilzomib and Belatacept (CarBel)
CLINICAL_TRIALS study record update · 2026-02-17
Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA: Diagnostic Performance and Transport Stability Across Shipping Conditions (CLEAR-CXCL10)
CLINICAL_TRIALS study record update · 2026-02-17
Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)
CLINICAL_TRIALS study record update · 2026-02-11
Using MSCs for Chronic Active Antibody Mediated Rejection
CLINICAL_TRIALS study record update · 2026-02-11
Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients With Tocilizumab ,IVIG, Plasmapheresis, Rituximab Versus IVIG, Plasmapheresis , Rituximab
CLINICAL_TRIALS study record update · 2026-02-10
AIIM Trial: Protecting Kidney Function After Transplantation Using Augmented Intelligence Based Immunosuppression Dosing
CLINICAL_TRIALS study record update · 2025-12-10
Platelet Aggregation in the Diagnosis of Acute Graft Rejection
CLINICAL_TRIALS study record update · 2025-12-10
AT-1501-K209: BESTOW-EXTENSION: A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
CLINICAL_TRIALS study record update · 2025-12-04
Long-Term Follow-Up of Patients Who Have Received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (CAR- Treg Therapy, TX200-TR101) in a Prior Clinical Study
CLINICAL_TRIALS study record update · 2025-11-20
Validation of Genomic Immune-phenotyping Profiles in Peripheral Blood Gene Signatures to Predict Risk of Kidney Transplant Rejection
CLINICAL_TRIALS study record update · 2025-11-19
GraftAssureDx Study: Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring
CLINICAL_TRIALS study record update · 2025-11-17
Post-Transplant Application of TruGraf and TRAC Molecular Panel in Renal Transplant Recipients
CLINICAL_TRIALS study record update · 2025-11-10
SIMPLE Study: A Prospective and Randomized Trial of a Simplified Immunosuppressive Protocol Utilizing Low Dose EnvarsusXR
CLINICAL_TRIALS study record update · 2025-10-29
AT-1501-K207: BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
CLINICAL_TRIALS study record update · 2025-07-17
Australian Genomics Of Chronic Allograft Dysfunction Study
CLINICAL_TRIALS study record update · 2025-07-08
Phase 1/2, Single-Arm, Open-Label Trial to Evaluate the Safety, Feasibility, and Immunogenicity of Ex Vivo CRISPR-Cas9 Gene-Edited Donor Kidneys (Knockout of HLA-A, HLA-B, and CIITA) in Human Renal Transplant Recipients
CLINICAL_TRIALS study record update · 2025-06-15
A Pilot Clinical Trial to Evaluate the Feasibility and Acceptability of: A Prospective, Unblinded, Randomized-controlled, Multicenter Biomarker Intervention Trial of a Urinary CXCL10 Clinical Surveillance Program in Pediatric Kidney Transplant Recipients for Early Ascertainment and Treatment of Subclinical Allograft Inflammation and Preservation of Kidney Transplant Function
CLINICAL_TRIALS study record update · 2025-06-15
Microbiome and Immunosuppression: The Mission Study
CLINICAL_TRIALS study record update · 2025-05-18
Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study
CLINICAL_TRIALS study record update · 2025-05-11
A Prospective, Observational Long-term Follow-up Trial of Kidney Transplant Patients Treated With Imlifidase or Plasma Exchange After an Active/Chronic Active Antibody-Mediated Rejection Episode